We serve Chemical Name:1H-[1,3]oxazolo[5,4-c]pyridin-2-one CAS:68523-29-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![1H-[1,3]oxazolo[5,4-c]pyridin-2-one](https://a.dearchem.com/CAS2/68523-29-5.png)
Chemical Name:1H-[1,3]oxazolo[5,4-c]pyridin-2-one
CAS.NO:68523-29-5
Synonyms:1H-[1,3]oxazolo[5,4-c]pyridin-2-one
Molecular Formula:C6H4N2O2
Molecular Weight:136.10800
HS Code:2934999090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:58.89000
Exact Mass:136.02700
LogP:0.51610
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1H-[1,3]oxazolo[5,4-c]pyridin-2-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1H-[1,3]oxazolo[5,4-c]pyridin-2-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1H-[1,3]oxazolo[5,4-c]pyridin-2-one Use and application,1H-[1,3]oxazolo[5,4-c]pyridin-2-one technical grade,usp/ep/jp grade.
Related News: Standard respiratory support therapies are used to treat the symptoms and wait for the virus to be cleared by itself. 1H-[1,3]oxazolo[5,4-c]pyridin-2-one manufacturer Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: ��Within the top 20 global companies that spent the most on R&D in 2018, the top spender �C despite having the second smallest annual revenue of the group at $15.28 billion �C is Celgene, whose R&D spend was equal to 37% of its annual revenue. 1H-[1,3]oxazolo[5,4-c]pyridin-2-one supplier Standard respiratory support therapies are used to treat the symptoms and wait for the virus to be cleared by itself. 1H-[1,3]oxazolo[5,4-c]pyridin-2-one vendor Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: ��Within the top 20 global companies that spent the most on R&D in 2018, the top spender �C despite having the second smallest annual revenue of the group at $15.28 billion �C is Celgene, whose R&D spend was equal to 37% of its annual revenue. 1H-[1,3]oxazolo[5,4-c]pyridin-2-one factory Over the years, large international pharmaceutical companies have gradually focused on the research and development and sales of patented drugs, and have gradually outsourced traditional products. Among them, most of the contractors are pharmaceutical companies in emerging countries.
